• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

CVS Health's Dan Knecht Talks 'Path to Better Health' Survey, Telehealth & More

Podcast

Briana Contreras speaks with Dan Knecht, Vice President of Clinical Product at CVS Health about telehealth, patient access, CVS minute clinics and Path to Better Health.

Briana Contreras, associate editor of Managed Healthcare Executive speaks with Dan Knecht, Vice President of Clinical Product at CVS Health in this week's episode. During the discussion, they spoke about telehealth, patient access to it, CVS minute clinics and most importantly, CVS Health’s recent study, Path to Better Health. This annual study includes responses from consumers and providers who were asked for their thoughts on the state of healthcare.

Dan Knecht, Vice President of Clinical Product at CVS Health

To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify, Apple Podcasts and iHeartRadio.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.